Baird Maintains Outperform on AdaptHealth, Raises Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Eric Coldwell maintains an Outperform rating on AdaptHealth (NASDAQ:AHCO) and raises the price target from $20 to $21.
July 13, 2023 | 11:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Eric Coldwell maintains an Outperform rating on AdaptHealth and raises the price target from $20 to $21.
The news is directly related to AdaptHealth. The Outperform rating maintained by Baird and the increase in price target from $20 to $21 indicates a positive outlook for the company. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100